Olivier Pasquier Joins CYTOO as Chief Commercial Officer
News Mar 18, 2013
Former Senior Marketing Manager Europe at QIAGEN, with more than 10 years experience in biology and biotechnology, he is passionate about biotech breakthroughs. He joins the team to lead the commercial success of CYTOO's 2D+ Cell Culture Platform and develop new markets in cell based assays and screening.
François Chatelain, CEO of CYTOO, says “We're delighted to welcome Olivier at CYTOO: I have no doubt that his insights, energy and business initiatives will be really impactful on CYTOO’s development!"
“It is an honour for me to join the executive team of CYTOO”, says Olivier Pasquier. “This company has a unique talented team, a breakthrough technology, a secured financial background, able to deeply change the game in the cell-based assay science. I want to make sure that every lab using cell culture in the world accesses micropatterns and scientific expertise available at CYTOO.”
CRISPR Used to Prevent Development of Angiogenesis of the RetinaNews
Powerful new technology may lead to novel therapies to prevent vision loss, blindness in those with diseases of the retina.READ MORE
Understanding the Cellular Systems that Hold Back the Spread of CancerNews
Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.READ MORE
Comments | 0 ADD COMMENT
8th International Symposium on Recent Advances in Food Analysis (RAFA 2017)
Nov 07 - Nov 10, 2017
6th Edition of International Conference on Pharmacognosy and Medicinal Plants
Apr 16 - Apr 17, 2018